Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | HTT | P42858 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.40 |
| ▸ | MGLL | Q99685 | 2/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14499572 | 0.88 | ALDH1A1 (0.53) | ALDH1A1HTTHSD17B10MAPK1SMN1; SMN2 | |
| SCHEMBL14499558 | 0.88 | MAPK1 (0.54) | ALDH1A1HTTHSD17B10MAPK1SMN1; SMN2 | |
| SCHEMBL14499578 | 0.86 | ALDH1A1 (0.54) | ALDH1A1HTTHSD17B10MAPK1SMN1; SMN2 | |
| SCHEMBL338566 | 0.86 | ALDH1A1 (0.57) | ALDH1A1HTTHSD17B10MAPK1SMN1; SMN2 | |
| SCHEMBL12912512 | 0.86 | ALDH1A1 (0.50) | ALDH1A1HTTHSD17B10MAPK1SMN1; SMN2 | |
| SCHEMBL14499576 | 0.86 | ALDH1A1 (0.59) | ALDH1A1HTTHSD17B10MAPK1SMN1; SMN2 | |
| SCHEMBL26344108 | 0.86 | MAPK1 (0.51) | ALDH1A1HTTHSD17B10MAPK1SMN1; SMN2 | |
| SCHEMBL14499571 | 0.85 | ALDH1A1 (0.53) | ALDH1A1HTTHSD17B10MAPK1SMN1; SMN2 | |
| SCHEMBL19310491 | 0.85 | ALDH1A1 (0.58) | ALDH1A1HTTHSD17B10MAPK1SMN1; SMN2 | |
| SCHEMBL14499574 | 0.85 | ALDH1A1 (0.58) | ALDH1A1HTTHSD17B10MAPK1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070138950-A1 | NITROGENOUS HETEROCYCLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2007-06-21 | — | — | US | disclosed |
| US-20070138950-A1 | NITROGENOUS HETEROCYCLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2007-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070138950-A1 | NITROGENOUS HETEROCYCLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME | EHD1, HCN2, ODC1 | ALDH1A1 2185/4885HTT 2253/4885HSD17B10 3508/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.